Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches

计划入组 25 人 · 首次发布于 2008 年 4 月 17 日

Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)

计划入组 1,038 人 · 首次发布于 2011 年 7 月 11 日

To Study the Peripheral Effect of Botulinum Toxin-A (Botox-A) on Experimentally Induced Cutaneous Pain in Healthy Subjects

首次发布于 2007 年 2 月 15 日

pMUC5AC (Allergan)

TKM Ebola(Protiva Biotherapeutics (USA), Inc.)

Cocaine hydrolase(Teva Biopharmaceuticals USA, Inc.)

Allergan, Inc.

United States

ALLERGAN MEDICAL

United States

ALLERGAN LIMITED

United Kingdom

Allergan Botox Patent Infringement Trial Against Revance Set for July in Delaware

Federal Circuit Reverses Patent Invalidation for Allergan's IBS-D Drug Viberzi in Landmark Double Patenting Case

Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM ... - USA Today